🇺🇸 FDA
Patent

US 9636329

Methods of treating cancer with glut inhibitors and oxidative phosphorylation inhibitors

granted A61KA61K31/155A61K31/427

Quick answer

US patent 9636329 (Methods of treating cancer with glut inhibitors and oxidative phosphorylation inhibitors) held by Northwestern University expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/155, A61K31/427, A61K45/06